Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients

被引：392

作者：

Chouliaras, Leonidas ^{[1
]}

Mastroeni, Diego ^{[1
,2
]}

Delvaux, Elaine ^{[2
]}

Grover, Andrew ^{[2
]}

Kenis, Gunter ^{[1
]}

Hof, Patrick R. ^{[3
,4
]}

Steinbusch, Harry W. M. ^{[1
]}

Coleman, Paul D. ^{[2
]}

Rutten, Bart P. F. ^{[1
]}

van den Hove, Daniel L. A. ^{[1
,5
]}

机构：

[1] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, European Grad Sch Neurosci EURON,Med Ctr, Dept Psychiat & Neuropsychol,Fac Hlth Med & Life, NL-6200 MD Maastricht, Netherlands

[2] Banner Sun Hlth Res Inst, Sun City, AZ USA

[3] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA

[4] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA

[5] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany

来源：

NEUROBIOLOGY OF AGING | 2013年 / 34卷 / 09期

基金：

美国国家卫生研究院;

关键词：

Alzheimer's disease; Epigenetics; DNA methylation; DNA hydroxymethylation; Amyloid; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; NEURONS; EXPOSURE; DAMAGE; CYCLE; PB;

D O I：

10.1016/j.neurobiolaging.2013.02.021

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

030301 [社会学]; 100201 [内科学];

摘要：

Epigenetic dysregulation of gene expression is thought to be critically involved in the pathophysiology of Alzheimer's disease (AD). Recent studies indicate that DNA methylation and DNA hydroxymethylation are 2 important epigenetic mechanisms that regulate gene expression in the aging brain. However, very little is known about the levels of markers of DNA methylation and hydroxymethylation in the brains of patients with AD, the cell-type specificity of putative AD-related alterations in these markers, as well as the link between epigenetic alterations and the gross pathology of AD. The present quantitative immunohistochemical study investigated the levels of the 2 most important markers of DNA methylation and hydroxymethylation, that is, 5-methylcytidine (5-mC) and 5-hydroxymethylcytidine (5-hmC), in the hippocampus of AD patients (n = 10) and compared these to non-demented, age-matched controls (n = 10). In addition, the levels of 5-hmC in the hippocampus of a pair of monozygotic twins discordant for AD were assessed. The levels of 5-mC and 5-hmC were furthermore analyzed in a cell-type and hippocampal subregion-specific manner, and were correlated with amyloid plaque load and neurofibrillary tangle load. The results showed robust decreases in the hippocampal levels of 5-mC and 5-hmC in AD patients (19.6% and 20.2%, respectively). Similar results were obtained for the twin with AD when compared to the non-demented co-twin. Moreover, levels of 5-mC as well as the levels of 5-hmC showed a significant negative correlation with amyloid plaque load in the hippocampus (r(p) = -0.539, p = 0.021 for 5-mC and r(p) = -0.558, p = 0.016 for 5-hmC). These human postmortem results thus strengthen the notion that AD is associated with alterations in DNA methylation and hydroxymethylation, and provide a basis for further epigenetic studies identifying the exact genetic loci with aberrant epigenetic signatures. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：2091 / 2099

页数：9

共 47 条

[1]

Genome-Wide DNA Methylation Differences Between Late-Onset Alzheimer's Disease and Cognitively Normal Controls in Human Frontal Cortex [J].